Search results
Results From The WOW.Com Content Network
The most accurate ultrasound test can detect 96% of ovarian cancers in postmenopausal women, new research suggests. The findings indicate that the test should replace the current standard of care ...
Two genes most commonly associated with some other women's cancers, BRCA1 and BRCA2, do not cause endometrial cancer. There is an apparent link with these genes but it is attributable to the use of tamoxifen, a drug that itself can cause endometrial cancer, in breast and ovarian cancers. [17]
Device for both vaginal ultrasonography and abdominal ultrasonography Transvaginal ultrasonography to check the location of an intrauterine device (IUD). The examination can be performed by transabdominal ultrasonography, generally with a full bladder which acts as an acoustic window to achieve better visualization of pelvis organs, or by transvaginal ultrasonography with a specifically ...
The finding on transvaginal ultrasound of a thin endometrial lining gives the physician a 99% negative predictive value that the patient does not have endometrial cancer. [3] If a patient had a prior endometrial sampling that was inconclusive, then a transvaginal ultrasound can be used to triage a woman with post-menopausal bleeding. [3]
Colorectal cancer rates are up for people under 65; cervical cancer is on the rise in women between 30 and 44 years old; and teens between 15 and 19 are more likely to develop adolescent cancers.
Uterine cancer is the fourth most common cancer in females in the UK (around 8,500 women were diagnosed with the disease in 2011), and it is the tenth most common cause of cancer death in females (around 2,000 women died in 2012). [23]
Breast cancer is the second-most-common cancer in US women. The report estimated that in 2024, about 310,720 new cases will be diagnosed and an estimated 42,250 women will die from the disease.
A negative MRI can rule out the presence of cancer to a high degree of certainty, making it an excellent tool for screening in patients at high genetic risk or radiographically dense breasts, and for pre-treatment staging where the extent of disease is difficult to determine on mammography and ultrasound. MRI can diagnose benign proliferative ...